Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

37.66
Delayed Data
As of 11:34am ET
 -0.045 / -0.12%
Today’s Change
37.36
Today|||52-Week Range
45.58
-5.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues9.5B8.8B9.3B9.9B
 
 
 
 
 
Cost of Goods Sold3.4B2.2B2.4B3.0B
 
 
 
 
 
Depreciation And Amortization428.2M790.4M569.0M250.6M
 
 
 
 
 
 
Operating ExpensesGross Income5.6B5.9B6.3B6.7B
 
 
 
 
 
General Expenses5.4B4.0B4.0B4.0B
 
 
 
 
 
Research And Development1.6B1.1B1.1B1.1B
 
 
 
 
 
Total Operating Expenses9.2B6.9B7.0B7.2B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income291.0M1.9B2.3B2.7B
 
 
 
 
 
Extraordinary Credit--0.000.0011.8M
 
 
Extraordinary Charge---956.1M-2.9B-1.3B
 
 
 
 
Interest Expense On Debt298.6M250.7M256.9M230.9M
 
 
 
 
 
Equity In Earnings-7.5M0.00-2.8M7.9M
 
 
 
 
Other Expenses-672.5M158.6M410.1M511.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-619.7M793.2M-448.4M1.7B
 
 
 
 
 
Income Taxes-18.1M-294.6M-246.9M-510.4M
 
 
 
 
 
Minority Interest-111.6M-99.2M-80.9M-101.0M
 
 
 
 
 
Net Income-533.8M399.4M-617.3M1.1B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.4B2.4B2.4B2.4B
 
 
 
 
 
Shares To Calculate EPS Diluted2.4B2.4B2.4B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS-$0.22$0.16-$0.26$0.44
 
 
 
 
 
EPS Diluted-$0.22$0.16-$0.26$0.43